mining_logo_mux_2019.jpg
McEwen Mining 2023 Results Conference Call
February 28, 2024 13:57 ET | McEwen Mining
TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) invites you to join our conference call following the release of our Q4 and year-end 2023 financials results on...
MacroGenics-Logo-(transparent-background).png
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
February 27, 2024 17:45 ET | MacroGenics, Inc.
ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based...
Chris Jackson, CEO of CyberloQ Technologies, Inc. and Luis Tujillo, Founder and Managing Partner of PAARC Consulting Outline the Evolution of Fraud in the Payments Industry and Their Efforts to Stop It
February 22, 2024 08:30 ET | SmallCapVoice.com and CyberloQ Technologies, Inc.
This in-depth conversation sheds light on their innovative strategies to combat cyber fraud, highlighting the impactful partnership between the two.
life.jpg
LifeVantage to Participate in the Winter Wrap Up MicroCap Rodeo Conference
February 16, 2024 08:00 ET | LifeVantage Corporation
SALT LAKE CITY, Feb. 16, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the...
blk_parkerlogo.jpg
Parker Scheduled to Present at Barclays 41st Annual Industrial Select Conference on February 21 at 10:20 a.m. Eastern Time
February 15, 2024 17:00 ET | Parker-Hannifin Corporation
CLEVELAND, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the...
Arbutus Biopharma Logo
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
February 15, 2024 07:30 ET | Arbutus Biopharma Corporation
WARMINSTER, Pa., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a...
Agios_2021_Logo.png
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
February 15, 2024 07:00 ET | Agios Pharmaceuticals, Inc.
Agios reports fourth quarter and full year 2023 financial results and recent business highlights
MYR Group logo
MYR Group Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Schedule
February 14, 2024 16:05 ET | MYR Group, Inc.
THORNTON, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) -- MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure,...
blk_parkerlogo.jpg
Parker Scheduled to Present at Citi’s 2024 Global Industrial Tech and Mobility Conference on February 20 at 11:20 a.m. Eastern Time
February 13, 2024 17:00 ET | Parker-Hannifin Corporation
CLEVELAND, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at Citi’s...
Adverum_Primary_Medium.png
Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024
February 01, 2024 17:30 ET | Adverum Biotechnologies, Inc.
- Preliminary safety and efficacy data from ongoing LUNA Phase 2 study of Ixo-vec for the treatment of wet AMD will be presented at the 47th Annual Meeting of the Macula Society, with...